Content
Shares Of China-Based Tesla Competitor Li Auto Surge In Nasdaq Trading Debut
Article By:
Tyler Durden
Read
Saturday, August 1, 2020 5:23 PM EDT
New Chinese startup Li Auto just saw major success upon listing its shares on the NASDAQ, proving that: a) the EV hype is still alive and b) U.S. investors have learned precisely nothing from watching one China-based fraud implode after another.
In this article: TSLA
The Week Ahead In Biotech: Spotlight On GW Pharma, Ultragenyx FDA Decisions, Pfizer Earnings
Jazz Awaits FDA Nod For Sleep Disorder Drug, Earnings Trickle In, ACell IPO
Week In Review: China Life Science Announces $5 Billion In Deals, A Weekly Record
Article By:
ChinaBio® Today
Read
Saturday, July 18, 2020 5:38 PM EDT
BeiGene, a Beijing oncology drug biopharma, announced a $2.1 billion private placement that will bring its cash holdings to almost $5.5 billion The company is developing a portfolio of 25 candidates, with several of them in Phase III tests.
Israeli Startup Deal Digest – June 2020
Article By:
Shelly Hod Moyal
Read
Thursday, July 16, 2020 5:04 AM EDT
This June we tracked 27 announced deals totaling approximately $560 Million, and 8 exits worth over $1.5 Billion.
The Week Ahead In Biotech: J&J Kickstarts Pharma Earnings, Repare Therapeutics IPO
Article By:
Benzinga
Read
Sunday, July 12, 2020 3:17 PM EDT
Biotech stocks advanced in the week ended July 10 amid mixed news emerging out of the sector. FDA approved a few drugs, including Endo International PLC's cellulite treatment, while Merck & Co. & Eisai Co.'s combo therapy was rejected by the FDA.
Week In Review: Ocumension Climbs To $2.5 Billion Market Cap After $184 Million Hong Kong IPO
Article By:
ChinaBio® Today
Read
Saturday, July 11, 2020 12:05 PM EDT
Ocumension, a Shanghai ophthalmic pharma, completed a $184 million Hong Kong IPO and climbed 152% in its first trading session, giving the company a valuation of about $2.5 billion. The company has raised $200 million in venture capital.